Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Context Therapeutics Inc. | 270,000 | reported | 19 Feb 2026 | tx 8+1,061,790 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 19 Feb 2026 | GRANT_AWARD | Context Therapeutics Inc. | 270,000 | 0.00 USD | deriv |
| 06 Jun 2025 | PURCHASE | Context Therapeutics Inc. | 20,000 | 0.58 USD | first after silence |
| 13 Feb 2025 | GRANT_AWARD | Context Therapeutics Inc. | 349,900 | 0.00 USD | deriv |
| 21 Mar 2024 | GRANT_AWARD | Context Therapeutics Inc. | 153,515 | 0.00 USD | deriv |
| 13 Feb 2023 | GRANT_AWARD | Context Therapeutics Inc. | 151,505 | 0.00 USD | deriv |
| 09 Dec 2022 | PURCHASE | Context Therapeutics Inc. | 6,000 | 0.85 USD | first after silence |
| 25 Feb 2022 | GRANT_AWARD | Context Therapeutics Inc. | 107,870 | 0.00 USD | deriv |
| 22 Oct 2021 | PURCHASE | Context Therapeutics Inc. | 3,000 | 5.00 USD |
2 purchases reported after at least 12 months of silence — most recent on 06 Jun 2025.